Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 50 Records) |
| Query Trace: Neoplasms and UGT2B7[original query] |
|---|
| Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751. Pharmacogenetics and genomics 2013 Jul 23 (7): 374-81. Innocenti Federico, Ramírez Jacqueline, Obel Jennifer, Xiong Julia, Mirkov Snezana, Chiu Yi-Lin, Katz David A, Carr Robert A, Zhang Wei, Das Soma, Adjei Araba, Moyer Ann M, Chen Pei Xian, Krivoshik Andrew, Medina Diane, Gordon Gary B, Ratain Mark J, Sahelijo Leonardo, Weinshilboum Richard M, Fleming Gini F, Bhathena Anahi |
| Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013 Feb . Vulsteke C, Lambrechts D, Dieudonné A, Hatse S, Brouwers B, van Brussel T, Neven P, Belmans A, Schöffski P, Paridaens R, Wildiers H |
| Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast cancer research and treatment 2014 Oct 147 (3): 557-70. Vulsteke C, Pfeil A M, Schwenkglenks M, Pettengell R, Szucs T D, Lambrechts D, Peeters M, van Dam P, Dieudonné A S, Hatse S, Neven P, Paridaens R, Wildiers |
| UGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Jan 24 (1): 94-104. Wassenaar Catherine A, Conti David V, Das Soma, Chen Peixian, Cook Edwin H, Ratain Mark J, Benowitz Neal L, Tyndale Rachel |
| Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients. PloS one 2015 10 (7): e0132269. Romero-Lorca Alicia, Novillo Apolonia, Gaibar María, Bandrés Fernando, Fernández-Santander A |
| Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. Cancer chemotherapy and pharmacology 2015 Apr 75 (4): 763-72. Joerger M, Huitema A D R, Boot H, Cats A, Doodeman V D, Smits P H M, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny T D, Beijnen J H, Schellens J H |
| A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer. Clinical breast cancer 2015 Sep . Sawyer Michael B, Pituskin Edith, Damaraju Sambasivarao, Bies Robert R, Vos Larissa J, Prado Carla M M, Kuzma Michelle, Scarfe Andrew G, Clemons Mark, Tonkin Katia, Au Heather-Jane, Koski Sheryl, Joy Anil A, Smylie Michael, King Karen, Carandang Diana, Damaraju Vijaya L, Hanson John, Cass Carol E, Mackey John |
| Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients. Clinical pharmacokinetics 2016 Apr . Sutiman Natalia, Lim Joanne Siok Liu, Muerdter Thomas E, Singh Onkar, Cheung Yin Bun, Ng Raymond Chee Hui, Yap Yoon Sim, Wong Nan Soon, Ang Peter Cher Siang, Dent Rebecca, Schroth Werner, Schwab Matthias, Khor Chiea Chuen, Chowbay Balr |
| Bisphenol-A glucuronidation in human liver and breast: identification of UDP-glucuronosyltransferases (UGTs) and influence of genetic polymorphisms. Xenobiotica; the fate of foreign compounds in biological systems 2016 Mar 1-10. Street Christina M, Zhu Zhaohui, Finel Moshe, Court Michael |
| A Comprehensive Meta-analysis of Case-Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016 Feb . Figlioli Gisella, Elisei Rossella, Romei Cristina, Melaiu Ombretta, Cipollini Monica, Bambi Franco, Chen Bowang, Köhler Aleksandra, Cristaudo Alfonso, Hemminki Kari, Gemignani Federica, Försti Asta, Landi Stefa |
| Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study. BMC cancer 2017 Dec 17 (1): 901. Falkowski Sabrina, Woillard Jean-Baptiste, Postil Deborah, Tubiana-Mathieu Nicole, Terrebonne Eric, Pariente Antoine, Smith Denis, Guimbaud Rosine, Thalamas Claire, Rouguieg-Malki Koukeb, Marquet Pierre, Picard Nicol |
| Association between UDP-glucuronosyltransferase 2B7 tagSNPs and breast cancer risk in Chinese females. Clinical and experimental pharmacology & physiology 2018 05 45 (5): 437-443. He Bao-Xia, Qiao Bin, Lam Alfred King-Yin, Zhao Xiu-Li, Zhang Wen-Zhou, Liu H |
| Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis 2017 Dec . Tang Li, Platek Mary E, Yao Song, Till Cathee, Goodman Phyllis J, Tangen Catherine M, Wu Yue, Platz Elizabeth A, Neuhouser Marian L, Stanczyk Frank Z, Reichardt Juergen K V, Santella Regina M, Hsing Ann, Figg William D, Lippman Scott M, Thompson Ian M, Ambrosone Christine |
| The impact of UGT2B7 C802T and CYP3A4*1G polymorphisms on pain relief in cancer patients receiving oxycontin. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2018 Mar . Li Jingwen, Peng Peng, Mei Qi, Xia Shu, Tian Yijun, Hu Liya, Chen Yu |
| Correlation of UGT2B7 Polymorphism with Cardiotoxicity in Breast Cancer Patients Undergoing Epirubicin/Cyclophosphamide-Docetaxel Adjuvant Chemotherapy. Yonsei medical journal 2019 Jan 60 (1): 30-37. Li Hai, Hu Bo, Guo Zhe, Jiang Xueqing, Su Xinyu, Zhang Xiao |
| RS7435335 located in the UGT2B7 gene may be a possible genetic marker for the clinical response and prognosis of breast cancer patients receiving neoadjuvant chemotherapy. Journal of cellular biochemistry 2018 Dec . Mou Peng, Wang HuiJun, An Liping, Yin Qiang, Chang Ju |
| Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters. Biological & pharmaceutical bulletin 2018 41 (1): 47-56. Endo-Tsukude Chihiro, Sasaki Ji-Ichiro, Saeki Sho, Iwamoto Norihiro, Inaba Megumi, Ushijima Sunao, Kishi Hiroto, Fujii Shinji, Semba Hiroshi, Kashiwabara Kosuke, Tsubata Yukari, Hayashi Mitsuhiro, Kai Yuki, Saito Hideyuki, Isobe Takeshi, Kohrogi Hirotsugu, Hamada Akino |
| Associations between UGT2B7 polymorphisms and cancer susceptibility: A meta-analysis. Gene 2019 May 706 115-123. Shen Ming-Li, Xiao An, Yin Sun-Jun, Wang Ping, Lin Xiao-Qian, Yu Chen-Bin, He Gong-H |
| Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case-Control Study. Clinical pharmacology and therapeutics 2019 Feb . Arbitrio Mariamena, Scionti Francesca, Altomare Emanuela, Di Martino Maria Teresa, Agapito Giuseppe, Galeano Teresa, Staropoli Nicoletta, Iuliano Eleonora, Grillone Francesco, Fabiani Fernanda, Caracciolo Daniele, Cannataro Mario, Arpino Grazia, Santini Daniele, Tassone Pierfrancesco, Tagliaferri Pierosand |
| [Effect of opioid-related gene polymorphisms on patients with high-dose opioid-tolerant cancer pain]. Zhonghua yi xue za zhi 2019 Dec 99 (47): 3720-3724. Xie G L, Zhang W, Li Z G, Guo D P, Liu |
| Roles of UGT2B7 C802T gene polymorphism on the efficacy of morphine treatment on cancer pain among the Chinese han population. Nigerian journal of clinical practice 2019 Oct 22 (10): 1319-1323. Ning M, Tao Y, Hu X, Guo L, Ni J, Hu J, Shen H, Chen |
| Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study. BMC cancer 2019 Dec 19 (1): 1257. Al-Eitan Laith N, Rababa'h Doaa M, Alghamdi Mansour A, Khasawneh Rame |
| Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance). Pharmacogenetics and genomics 2021 Jun . Patel Jai N, Jiang Chen, Owzar Kouros, Mulkey Flora, Luzum Jasmine A, Mamon Harvey J, Haller Daniel G, Dragovich Tomislav, Alberts Steven R, Bjarnason Georg, Willet Christopher G, Niedzwiecki Donna, Enzinger Peter, Ratain Mark J, Fuchs Charles, McLeod Howard |
| Comprehensive signature analysis of drug metabolism differences in the White, Black and Asian prostate cancer patients. Aging 2021 6 13 (12): 16316-16340. Liu Yang, Zhou Jia-Wei, Liu Cun-Dong, Yang Jian-Kun, Liao De-Ying, Liang Zhi-Jian, Xie Xiao, Zhou Qi-Zhao, Xue Kang-Yi, Guo Wen-Bing, Xia Ming, Zhou Jun-Hao, Bao Ji-Ming, Yang Cheng, Duan Hai-Feng, Wang Hong-Yi, Huang Zhi-Peng, Zhao Shan-Chao, Chen Ming-K |
| Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer. Clinical breast cancer 2021 Mar . Joy Anil A, Vos Larissa J, Pituskin Edith, Cook Sarah F, Bies Robert R, Vlahadamis Ann, King Karen, Basi Sanraj K, Meza-Junco Judith, Mackey John R, Stanislaus Avalyn, Damaraju Vijaya L, Damaraju Sambasivarao, Sawyer Michael |
| Association between sex hormones regulation-related SNP rs12233719 and lung cancer risk among never-smoking Chinese women. Cancer medicine 2021 Feb . Qian Ying, Xie Li, Li Lei, Feng Tienan, Zhu Tengteng, Wang Ruoyang, Yang Yuqing, Zhou Baosen, Yu Herbert, Qian Biy |
| Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients. Frontiers in pharmacology 2021 12 12 661443. Miranda Carla, Galleguillos Macarena, Torres Roberto, Tardón Karla, Cáceres Dante D, Lee Kuen, Redal María A, Varela Nelson M, Quiñones Luis |
| Value of UGT2B7-161 Single Nucleotide Polymorphism in Predicting the Risk of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Who Underwent Pertuzumab Combined with Trastuzumab Therapy by PSL. Pharmacogenomics and personalized medicine 2022 3 15 215-225. Li Jian, Luo Hui, Liu Ying-Ying, Chen Li-Xin, Zhu Mei-Qin, Deng Quan-Tong, Zhu Dong-Mei, Wang Zi-Mo, Xu Jin-Fe |
| Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma. Molecular and cellular biochemistry 2022 12 . Matsumoto Jun, Nishimoto Anzu, Watari Shogo, Ueki Hideo, Shiromizu Shoya, Iwata Naohiro, Takeda Tatsuaki, Ushio Soichiro, Kajizono Makoto, Fujiyoshi Masachika, Koyama Toshihiro, Araki Motoo, Wada Koichiro, Zamami Yoshito, Nasu Yasutomo, Ariyoshi Norita |
| Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy. Fundamental & clinical pharmacology 2023 10 . Ivana Šušak Sporiš, Nada Božina, Iva Klarica Domjanovi?, Davor Sporiš, Silvio Baši?, Ivana Baši?, Mila Lovri?, Lana Ganoci, Vladimir Trkul |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 28, 2023
- Content source: